None
Quote | SI-BONE Inc. (NASDAQ:SIBN)
Last: | $15.56 |
---|---|
Change Percent: | 0.0% |
Open: | $15.42 |
Close: | $15.56 |
High: | $15.64 |
Low: | $15.18 |
Volume: | 482,848 |
Last Trade Date Time: | 04/22/2024 03:00:00 am |
News | SI-BONE Inc. (NASDAQ:SIBN)
SANTA CLARA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy today announced it will report financial results for the first quarter of 2024 after market close on Monday, May...
2024-04-14 17:56:08 ET More on Boston Scientific, CONMED, etc. ResMed: Not A Sleeper Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Mizuho sees ResMed as 'overwhelming ben...
Message Board Posts | SI-BONE Inc. (NASDAQ:SIBN)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $SIBN News Article - SI-BONE Announces Preliminary Revenue for the Fourth Quarter and F | whytestocks | investorshangout | 01/09/2023 3:50:48 PM |
whytestocks: $SIBN News Article - SI-BONE, Inc. Announces FDA Clearance for Expanded Rod Compatibili | whytestocks | investorshangout | 12/27/2022 4:25:45 PM |
whytestocks: $SIBN News Article - SI-BONE To Report Third Quarter 2022 Financial Results on November | whytestocks | investorshangout | 10/17/2022 8:15:56 PM |
whytestocks: $SIBN News Article - SI-BONE To Present at The Morgan Stanley 20th Annual Global Health | whytestocks | investorshangout | 08/23/2022 12:50:57 PM |
whytestocks: $SIBN News Article - SI-BONE, Inc. Receives FDA 510(k) Clearance for iFuse Bedrock Gran | whytestocks | investorshangout | 05/31/2022 5:40:52 PM |
News, Short Squeeze, Breakout and More Instantly...
SANTA CLARA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving musculoskelet...
SANTA CLARA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy today announced it will report financial results for the first quarter of 2024 after market close on Monday, May...
2024-03-28 16:30:02 ET Piper Sandler analyst issues BUY recommendation for SIBN on March 28, 2024 03:00PM ET. The previous analyst recommendation was Buy. SIBN was trading at $16.25 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...